Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Tildrakizumab for Genital Psoriasis
Recruiting1 awardPhase 3
Encino, California
This trial is testing a new medication called tildrakizumab for people with moderate to severe genital psoriasis to see if it is effective and safe when given as an injection under the skin
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service